BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38138584)

  • 1. Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt's Lymphoma (BL).
    Byrne AJ; Bright SA; McKeown JP; Bergin A; Twamley B; McElligott AM; Noorani S; Kandwal S; Fayne D; O'Boyle NM; Williams DC; Meegan MJ
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Antiproliferative and Pro-Apoptotic Effects of Nitrostyrenes and Related Compounds in Burkitt's Lymphoma.
    Byrne AJ; Bright SA; Fayne D; McKeown JP; McCabe T; Twamley B; Williams C; Meegan MJ
    Med Chem; 2018 Feb; 14(2):181-199. PubMed ID: 28969575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt's Lymphoma.
    Byrne AJ; Bright SA; McKeown JP; O'Brien JE; Twamley B; Fayne D; Williams DC; Meegan MJ
    Pharmaceuticals (Basel); 2020 Jan; 13(1):. PubMed ID: 31963567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
    Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
    Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.
    Bright SA; Byrne AJ; Vandenberghe E; Browne PV; Mcelligott AM; Meegan MJ; Williams DC
    Oncol Rep; 2019 May; 41(5):3127-3136. PubMed ID: 30896840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
    Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
    Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiproliferative action of a novel series of maprotiline analogues.
    McNamara YM; Bright SA; Byrne AJ; Cloonan SM; McCabe T; Williams DC; Meegan MJ
    Eur J Med Chem; 2014 Jan; 71():333-53. PubMed ID: 24333581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concanavalin A receptors on the surface membrane of lymphocytes from patients with Burkitt's lymphoma, other malignant lymphomas, leukaemia and lymphoma cell lines.
    Ben-Bassat H; Goldblum N
    IARC Sci Publ (1971); 1978; (24 Pt 2):639-47. PubMed ID: 751902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
    Klein SC; Jücker M; Abts H; Tesch H
    Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
    Schriever F; Huhn D
    Drugs; 2003; 63(10):953-69. PubMed ID: 12699399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
    J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
    Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
    Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
    Mori N; Ishikawa C; Senba M; Kimura M; Okano Y
    Biochem Pharmacol; 2011 May; 81(9):1106-15. PubMed ID: 21371446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.
    Benjamin D; Knobloch TJ; Dayton MA
    Blood; 1992 Sep; 80(5):1289-98. PubMed ID: 1325212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H
    Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.